Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
25%(2 trials)

Phase Distribution

Ph phase_3
2
22%
Ph phase_1
2
22%
Ph phase_4
2
22%
Ph phase_2
3
33%

Phase Distribution

2

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(8)
Terminated(1)

Detailed Status

Completed8
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (22.2%)
Phase 23 (33.3%)
Phase 32 (22.2%)
Phase 42 (22.2%)

Trials by Status

withdrawn111%
completed889%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_4

Direct Mechanical Thrombectomy Versus Bridging Therapy

NCT05155540
completedphase_4

Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism

NCT02396758
completedphase_3

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy

NCT01513759
completedphase_3

Thrombolysis Endovascular Treatment of Pulmonary Embolism

NCT03966079
withdrawnphase_2

Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke

NCT01133223
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05155540Phase 4

Direct Mechanical Thrombectomy Versus Bridging Therapy

Completed
NCT02396758Phase 4

Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism

Completed
NCT01513759Phase 3

Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy

Completed
NCT03966079Phase 3

Thrombolysis Endovascular Treatment of Pulmonary Embolism

Completed
NCT01133223Phase 2

Safety and Efficacy of the Penumbra™ System in Acute Middle Cerebral Artery (MCA) Stroke

Withdrawn
NCT01678495Phase 2

Sonothrombolysis Potentiated by Microbubbles for Acute Ischemic Stroke

Completed
NCT00243906Phase 2

Interventional Management of Stroke (IMS) II Study

Completed
NCT00086723Phase 1

In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer

Completed
NCT00001713Phase 1

Treatment for Blood Clots in the Veins of the Legs

Completed

All 9 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
9